dc.creatorPitanga, Thassila Nogueira
dc.creatorVilas-Boas, Wendell
dc.creatorCerqueira, Bruno Antonio Veloso
dc.creatorSeixas, Magda Oliveira
dc.creatorBarbosa, Cynara Gomes
dc.creatorAdorno, Elisângela Vitória
dc.creatorGoncalves, Marilda Souza
dc.date2016-05-05T18:29:08Z
dc.date2016-05-05T18:29:08Z
dc.date2013
dc.date.accessioned2023-09-26T20:15:03Z
dc.date.available2023-09-26T20:15:03Z
dc.identifierPITANGA, Thassila Nogueira et al. Cytokine profiles in sickle cell anemia: Pathways to be unraveled. Advances in Bioscience and Biotechnology, v. 4, p. 6-12, 2013.
dc.identifier2156-8456
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/14106
dc.identifier10.4236/abb.2013.47A1002
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8852476
dc.descriptionSickle cell anemia (SCA) is a genetically inherited hemolytic disorder characterized by chronic inflam- mation. Cytokine expression affects the pivotal path- ways that contribute to disease pathogenesis, but the mechanisms involved are not well understood. SCA is associated with a proinflammatory state, and an en- hanced inflammatory response occurs during vaso- occlusive crisis. The immune system thus plays an important role in this inflammatory condition, with several cell types secreting pro-inflammatory cyto- kines that contribute to the occurrence of common cyclical events in SCA patients, such as hemolysis, vascular occlusion and inflammation. Studies of these cytokines and chemokines in SCA patients have clari- fied the mechanisms that underlie this disease and highlighted the need for a better understanding of cytokine participation in SCA pathophysiology
dc.formatapplication/pdf
dc.languageeng
dc.publisherScientific Research Publishing
dc.rightsopen access
dc.subjectSickle Cell Anemia
dc.subjectCytokines
dc.subjectChemokine
dc.subjectInflammation
dc.subjectInflammasome
dc.titleCytokine profiles in sickle cell anemia: Pathways to be unraveled
dc.typeArticle


Este ítem pertenece a la siguiente institución